Medications for Cystic Fibrosis

5 results
  • alyftrek - vanzacaftor, tezacaftor, and deutivacaftor tablet, film coated

    (Vanzacaftor, Tezacaftor, And Deutivacaftor)
    Vertex Pharmaceuticals Incorporated
    Alyftrek treats cystic fibrosis (CF) in adults and children 6 years and older with at least one CFTR gene variant responsive to treatment or that produces CFTR protein.
  • kalydeco - ivacaftor tablet, film coated

    (Ivacaftor)
    Vertex Pharmaceuticals Incorporated
    Kalydeco treats cystic fibrosis (CF) in patients aged 1 month and older who have at least one CFTR gene mutation responsive to ivacaftor potentiation, confirmed by clinical data, in vitro assay, or FDA-cleared CF mutation testing.
  • orkambi - lumacaftor and ivacaftor tablet, film coated

    (Lumacaftor And Ivacaftor)
    Vertex Pharmaceuticals Incorporated
    Orkambi treats cystic fibrosis (CF) in patients aged 1 year and older who are homozygous for the F508del CFTR gene mutation. Not established for CF patients with other mutations.
  • symdeko - tezacaftor and ivacaftor

    (Tezacaftor And Ivacaftor)
    Vertex Pharmaceuticals Incorporated
    Symdeko treats cystic fibrosis (CF) in patients 6 and older who are homozygous for the F508del mutation or have at least one CFTR gene mutation responsive to tezacaftor/ivacaftor, based on in vitro data or clinical evidence.
  • trikafta - elexacaftor, tezacaftor, and ivacaftor

    (Elexacaftor, Tezacaftor, And Ivacaftor)
    Vertex Pharmaceuticals Incorporated
    Trikafta treats cystic fibrosis (CF) in adults and pediatric patients aged 2 and older who have at least one CFTR gene variant that is responsive to treatment or results in CFTR protein production.